The inaugural meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committe (MC) was held on June 2nd and 3rd 2018 in Kobe, Japan with the participation of 20 IPRP

Back in 2016, discussions started about a possible consolidation of the two initiatives, the International Generic Drug Regulators Programme (IGDRP) and the International Pharmaceutical Regulators

Back in 2016, discussions started about a possible consolidation of the two initiatives, the International Generic Drug Regulators Programme (IGDRP) and the International Pharmaceutical Regulators

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Geneva, Switzerland on November 12-13, 2017. Celia Lourenco (Chair, Health Canada), Bianca Zimon (Co

The Steering Committee (SC) of the International Generic Drug Regulators Programme (IGDRP) met in Brasilia, Brazil on November 1-2, 2017. The Chair, ANVISA and Co-Chair (Health Canada), together with

Members and Observers of the International Generic Drug Regulators Programme (IGDRP)participated in its 5th meeting which took place in Ottawa, Canada from June 5th-8th, 2017. Concurrent meetings

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Montreal, Canada, May 28-29, 2017.   Joan Blair (Chair, US FDA), Bianca Zimon (Co-Chair,

The Members of the International Generic Drug Regulators Programme (IGDRP) participated in its 4th meeting held in Mexico, from 17 to 20 October 2016. The Members focused primarily on the future

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Osaka, Japan, November 6-7, 2016. During this meeting, the MC endorsed elements for a long-term

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Lisbon, Portugal, June 12-13,  2016. It continued a strategy development process that had been